Carlo Fumagalli

20PUBLICATIONS
93CO-AUTHORS
Gene and molecular therapyCardiology (incl. cardiovascular diseases)Gene expression (incl. microarray and other genome-wide approaches)Rheumatology and arthritisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 12, 2026
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy.

|May 26, 2026
Value of Coronary CT Angiography in Ruling Out Coronary Artery Disease in Elderly Patients Candidates to TAVI.

|Apr 09, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact.

Francesco Cappelli, Carlo Fumagalli, Marco Luigetti

|Feb 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.

Mattia Zampieri, Giulia Biagioni, Annamaria Del Franco

|Sep 30, 2025
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug.

Stefano Fumagalli, Melania Dovizio, Stefania Mazzoni

|Jul 02, 2025
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study.

Carlo Fumagalli, Mattia Zampieri, Roberto Presta

Pageof 4

Frequent Collaborators

7 joint publications

Francesco Cappelli

6 joint publications

Iacopo Olivotto

5 joint publications

Niccolò Marchionni

5 joint publications

Federico Perfetto